Search research articles
Contact Us
Filters
Showing results (11-20 of 68) with videos related to
Page
of 7
Sort By:
British Journal of Haematology
|
February 28, 2014
Central nervous system multiple myeloma: a different cytogenetic profile
Alessandro Gozzetti, Adele Frasconi, Rosaria Crupi, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 20, 2012
Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET
Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, et al.
Cancer Genetics and Cytogenetics
|
June 2, 2009
Isolated deletion of 6q in a patient with myelodysplastic syndrome
Alessandro Gozzetti, Rosaria Crupi, Marzia Defina, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 21, 2020
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia
Vincenzo Sammartano, Adele Santoni, Marzia Defina, et al.
Leukemia Research
|
July 20, 2011
A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report
Alessandro Gozzetti, Alfonso Cerase, Rosaria Crupi, et al.
Leukemia Research
|
June 19, 2010
Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia, et al.
Hematology (Amsterdam, Netherlands)
|
November 9, 2005
Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia
Giuseppe Marotta, Monica Tozzi, Simona Sammassimo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 13, 2010
Weekly bortezomib, pegylated liposomal doxorubicin, and dexamethasone is a safe and effective therapy for elderly patients with relapsed/refractory multiple myeloma
Alessandro Gozzetti, Alberto Fabbri, Stefania Oliva, et al.
Leukemia Research
|
October 14, 2011
Extramedullary multifocal plasmacytoma relapse in multiple myeloma
Alessandro Gozzetti, Elena Marchini, Benedetta Banchi, et al.
Onkologie
|
February 13, 2008
Unusual discordant responses in two multiple myeloma patients during bortezomib treatment
Maria Teresa Pirrotta, Alessandro Gozzetti, Alfonso Cerase, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 68) with videos related to
Sort By:
Page
of 7
British Journal of Haematology
|
February 28, 2014
Central nervous system multiple myeloma: a different cytogenetic profile
Alessandro Gozzetti, Adele Frasconi, Rosaria Crupi, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 20, 2012
Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET
Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, et al.
Cancer Genetics and Cytogenetics
|
June 2, 2009
Isolated deletion of 6q in a patient with myelodysplastic syndrome
Alessandro Gozzetti, Rosaria Crupi, Marzia Defina, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 21, 2020
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia
Vincenzo Sammartano, Adele Santoni, Marzia Defina, et al.
Leukemia Research
|
July 20, 2011
A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report
Alessandro Gozzetti, Alfonso Cerase, Rosaria Crupi, et al.
Leukemia Research
|
June 19, 2010
Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia, et al.
Hematology (Amsterdam, Netherlands)
|
November 9, 2005
Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia
Giuseppe Marotta, Monica Tozzi, Simona Sammassimo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 13, 2010
Weekly bortezomib, pegylated liposomal doxorubicin, and dexamethasone is a safe and effective therapy for elderly patients with relapsed/refractory multiple myeloma
Alessandro Gozzetti, Alberto Fabbri, Stefania Oliva, et al.
Leukemia Research
|
October 14, 2011
Extramedullary multifocal plasmacytoma relapse in multiple myeloma
Alessandro Gozzetti, Elena Marchini, Benedetta Banchi, et al.
Onkologie
|
February 13, 2008
Unusual discordant responses in two multiple myeloma patients during bortezomib treatment
Maria Teresa Pirrotta, Alessandro Gozzetti, Alfonso Cerase, et al.
Page
of 7